MyHealthTeams and the Global Vitiligo Foundation Team to Bring Consumer-Relevant, Medically Reviewed Content to the Vitiligo Community

FacebookFacebookTwitterTwitterEmailEmailLinkedInLinkedInWhatsAppWhatsAppMessengerMessengerFlipboardFlipboardGmailGmailTelegramTelegramShareShare

SAN FRANCISCO, March 3, 2020 /PRNewswire/ — MyHealthTeams, creator of the largest and fastest-growing social networks for people facing chronic health conditions, today announced its collaboration with the Global Vitiligo Foundation, an organization whose mission is to improve the quality of life for individuals with vitiligo through education, research, clinical care and community support. Together, the two will bring relevant, trusted health education information and resources to people via MyVitiligoTeam, a social network designed just for people facing vitiligo.

Launched in January 2020, more than 1,000 registered members have already joined MyVitiligoTeam, the 34th condition-specific social network created by MyHealthTeams. Reflecting a shared commitment to improving quality of life for people living with vitiligo, the two organizations will create and publish medically reviewed content featured within the social network. Members of the social network will be invited to join “Ask the Vitiligo Specialist” Q&A sessions throughout the year, and MyVitiligoTeam will participate in events including the Global Vitiligo Foundation’s Annual Scientific Symposium, World Vitiligo Day – USA, and the Vitiligo International Symposium meeting.

“As a kid diagnosed with vitiligo, I didn’t know anyone else facing the condition and I wasn’t sure where to find good information about it,” said Eric Peacock, co-founder and CEO of MyHealthTeams. “MyVitiligoTeam and our collaboration with the Global Vitiligo Foundation changes all that. Now, people can easily connect with others just like them and tap into relevant medical information.”

Vitiligo is an autoimmune condition where melanocytes, the cells responsible for skin pigmentation, are destroyed by the immune system, leaving light patches of skin. More than 70 million people worldwide have vitiligo, and an estimated 30% are children. Many people living with vitiligo report feeling isolated, as the disease is widely misunderstood and difficult to hide. There is no known cure.

About MyHealthTeams
MyHealthTeams believes that if you are diagnosed with a chronic condition, it should be easy to find and connect with others like you. MyHealthTeams creates social networks for people living with a chronic health condition. Millions of people have joined one of the company’s 35 highly engaged communities focusing on the following conditions: Crohn’s and colitis, multiple sclerosis, lupus, fibromyalgia, pulmonary hypertension, spondylitis, eczema, myeloma, hyperhidrosis, vitiligo, rheumatoid arthritis, psoriasis, leukemia, lymphoma, irritable bowel syndrome, Parkinson’s, Alzheimer’s, epilepsy, hemophilia, hidradenitis suppurative, depression, heart disease, type 2 diabetes, osteoporosis, COPD, chronic pain, migraines, food allergies, obesity, HIV, PCOS, endometriosis, breast cancer and autism.  MyHealthTeams’ social networks are available in 13 countries.

Media Contact
Michelle Cox
press@myhealthteams.com
415-823-7574

View original content to download multimedia:http://www.prnewswire.com/news-releases/myhealthteams-and-the-global-vitiligo-foundation-team-to-bring-consumer-relevant-medically-reviewed-content-to-the-vitiligo-community-301015793.html

SOURCE MyHealthTeams

Staff

Recent Posts

FinThrive Introduces Agentic AI at HFMA 2025 to Help Customers Transform Healthcare Revenue Cycle Management Performance

Company to also highlight advancements in denials and underpayments management and speak to the measurable…

7 hours ago

FinThrive Debuts Denials and Underpayments Analyzer, a Unified Solution for Denials and Underpayments, at HFMA 2025

Next generation analyzer helps hospitals protect revenue before it's lost by delivering timely end-to-end visibility…

7 hours ago

Novo Nordisk A/S: CagriSema 2.4 mg / 2.4 mg demonstrated 22.7% mean weight reduction in adults with overweight or obesity in REDEFINE 1, published in New England Journal of Medicine

Data presented simultaneously at the American Diabetes Association’s® 85th Scientific Sessions, showed mean weight reduction…

10 hours ago

Dr. Anosh Ahmed Advances Chicago Crypto Hub Project as Federal Support for Blockchain Grows

Dr. Anosh Ahmed repurposes West Side warehouse into blockchain innovation center, targeting 250+ jobs and…

10 hours ago

Dr. Anosh Ahmed Advances Chicago Crypto Hub Project Amid National Pro-Crypto Policy Shift

Dr. Anosh Ahmed converts vacant West Side warehouse into blockchain innovation hub, creating 250+ jobs…

10 hours ago

BioAge Labs to Present Preclinical Data on APJ Agonism for Diabetic Obesity and Heart Failure at the American Diabetes Association (ADA) 85th Scientific Sessions

Treatment with apelin receptor agonist enhanced glycemic control and demonstrated cardioprotective effects, with additive benefits…

10 hours ago